Erratum: Spatio-temporal expression and functional involvement of transient receptor potential vanilloid 1 in diabetic mechanical allodynia in rats (PLoS ONE (2014) 9, 7 (e102052) DOI: 10.1371/journal.pone.0102052);Spatio-temporal expression and functional involvement of transient receptor potential vanilloid 1 in diabetic mechanical allodynia in rats

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Cui, Yuan Yuan ^a,b   Xu, Hao ^a   Wu, Huang Hui ^c   Qi, Jian ^a   Shi, Juan ^a   Li, Yun Qing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b XI'AN MEDICAL UNIVERSITY   (China)

^c FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CAPSAZEPINE; MESSENGER RNA; RUTHENIUM RED; CAPSAICIN; STREPTOZOCIN; TRPV1 PROTEIN, RAT; VANILLOID RECEPTOR;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNTING; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MECHANICAL ALLODYNIA; DRUG MEGADOSE; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; LOW DRUG DOSE; MOUSE; NOCICEPTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPATIOTEMPORAL ANALYSIS; SPINAL GANGLION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT OUTCOME; TRPV1 GENE; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANALYSIS OF VARIANCE; ANIMAL; ANTAGONISTS AND INHIBITORS; DIABETIC NEUROPATHY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HYPERALGESIA; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD; TIME;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CAPSAICIN; DIABETIC NEUROPATHIES; FLUORESCENT ANTIBODY TECHNIQUE; GANGLIA, SPINAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HYPERALGESIA; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; RATS; REAL-TIME POLYMERASE CHAIN REACTION; RUTHENIUM RED; SPINAL CORD; STREPTOZOCIN; TIME FACTORS; TRPV CATION CHANNELS;

EID: 84904244404     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110164     Document Type: Erratum

References (52)

1. Veves A, Backonja M, Malik RA (2008) Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med 9: 660-674.
2. Morrow TJ (2004) Animal models of painful diabetic neuropathy: the STZ rat model. Curr Protoc Neurosci Chapter 9: Unit 9. 18.
3. Obrosova IG (2009) Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics 6: 638-647.
4. Khan GM, Chen SR, Pan HL (2002) Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats. Neuroscience 114: 291-299. (Pubitemid 35245410)
5. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, et al. (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389: 816-824. (Pubitemid 27462969)
6. De Petrocellis L, Moriello AS (2013) Modulation of the TRPV1 channel: current clinical trials and recent patents with focus on neurological conditions. Recent Pat CNS Drug Discov. 8:180-204.
7. Tominaga M, Julius D (2000) Capsaicin receptor in the pain pathway. Jpn J Pharmacol 83: 20-24. (Pubitemid 30352652)
8. Huang J, Zhang X, McNaughton PA (2006) Inflammatory pain: the cellular basis of heat hyperalgesia. Curr Neuropharmacol 4: 197-206.
9. Xiao L, Cheng J, Zhuang Y, Qu W, Muir J, et al. (2013) Botulinum toxin type A reduces hyperalgesia and TRPV1 expression in rats with neuropathic pain. Pain Med 14: 276-286.
10. Palazzo E, Luongo L, de Novellis V, Berrino L, Rossi F, et al. (2010) Moving towards supraspinal TRPV1 receptors for chronic pain relief. Mol Pain 6: 66.
11. Walker KM, Urban L, Medhurst SJ, Patel S, Panesar M, et al. (2003) The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 304: 56-62. (Pubitemid 36008912)
12. Sugimoto Y, Kojima Y, Inayoshi A, Inoue K, Miura-Kusaka H, et al. (2013) K-685, a TRPV1 antagonist, blocks PKC-sensitized TRPV1 activation and improves the inflammatory pain in a rat complete Freund's adjuvant model. J Pharmacol Sci 123: 256-266.
13. Kasama S, Kawakubo M, Suzuki T, Nishizawa T, Ishida A, et al. (2007) RNA interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat. Eur J Neurosci 25: 2956-2963. (Pubitemid 46888823)
14. Naruse K, Sato J, Funakubo M, Hata M, Nakamura N, et al. (2011) Transplantation of bone marrow-derived mononuclear cells improves mechanical hyperalgesia, cold allodynia and nerve function in diabetic neuropathy. PLoS One 6: e27458.
15. Pabbidi RM, Cao DS, Parihar A, Pauza ME, Premkumar LS (2008) Direct role of streptozotocin in inducing thermal hyperalgesia by enhanced expression of transient receptor potential vanilloid 1 in sensory neurons. Mol Pharmacol 73: 995-1004. (Pubitemid 351397904)
16. Bishnoi M, Bosgraaf CA, Abooj M, Zhong L, Premkumar LS (2011) Streptozotocin-induced early thermal hyperalgesia is independent of glycemic state of rats: role of transient receptor potential vanilloid 1(TRPV1) and inflammatory mediators. Mol Pain 7: 52.
17. Tominaga M, Caterina MJ (2004) Thermosensation and pain. J Neurobiol 61: 3-12. (Pubitemid 39302620)
18. Sharif Naeini R, Witty MF, Seguela P, Bourque CW (2006) An N-terminal variant of Trpv1 channel is required for osmosensory transduction. Nat Neurosci 9: 93-98. (Pubitemid 43011914)
19. Ciura S, Bourque CW (2006) Transient receptor potential vanilloid 1 is required for intrinsic osmoreception in organum vasculosum lamina terminalis neurons and for normal thirst responses to systemic hyperosmolality. J Neurosci 26: 9069-9075. (Pubitemid 44319398)
20. Daly D, Rong W, Chess-Williams R, Chapple C, Grundy D (2007) Bladder afferent sensitivity in wild-type and TRPV1 knockout mice. J Physiol 583: 663-674. (Pubitemid 47343496)
21. Murthy K, Harrington JT, Siegel RD (2005) Profound hypokalemia in diabetic ketoacidosis: a therapeutic challenge. Endocr Pract 11: 331-334.
22. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.
23. Sun W, Miao B, Wang XC, Duan JH, Ye X, et al. (2012) Gastrodin inhibits allodynia and hyperalgesia in painful diabetic neuropathy rats by decreasing excitability of nociceptive primary sensory neurons. PLoS one 7: e39647.
24. Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32: 77-88.
25. Wu HH, Yin JB, Zhang T, Cui YY, Dong YL, et al. (2014) Inhibiting spinal neuron-astrocytic activation correlates with synergistic analgesia of dexmedetomidine and ropivacaine. PLoS One 9: e92374.
26. Sekino Y, Nakano J, Hamaue Y, Chuganji S, Sakamoto J, et al. (2014) Sensory hyperinnervation and increase in NGF, TRPV1 and P2X3 expression in the epidermis following cast immobilization in rats. Eur J Pain 18: 639-648.
27. Hammond DL, Ackerman L, Holdsworth R, Elzey B (2004) Effects of spinal nerve ligation on immunohistochemically identified neurons in the L4 and L5 dorsal root ganglia of the rat. J Comp Neurol 475: 575-589. (Pubitemid 38859367)
28. Molliver DC, Wright DE, Leitner ML, Parsadanian AS, Doster K, et al. (1997) IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life. Neuron 19: 849-861. (Pubitemid 27471389)
29. Holzer P, Holzer-Petsche U (2009) Pharmacology of inflammatory pain: local alteration in receptors and mediators. Dig Dis 27 Suppl 1: 24-30.
30. Jakkamsetti V, Tsai NP, Gross C, Molinaro G, Collins KA, et al. (2013) Experience-induced Arc/Arg3.1 primes CA1 pyramidal neurons for metabotropic glutamate receptor-dependent long-term synaptic depression. Neuron 80: 72-79.
31. Ugawa S, Ueda T, Yamamura H, Shimada S (2005) In situ hybridization evidence for the coexistence of ASIC and TRPV1 within rat single sensory neurons. Brain Res Mol Brain Res 136: 125-133. (Pubitemid 40704615)
32. Hara T, Chiba T, Abe K, Makabe A, Ikeno S, et al. (2013) Effect of paclitaxel on transient receptor potential vanilloid 1 in rat dorsal root ganglion. Pain 154: 882-889.
33. Ma W, Zhang Y, Bantel C, Eisenach JC (2005) Medium and large injured dorsal root ganglion cells increase TRPV-1, accompanied by increased alpha2Cadrenoceptor co-expression and functional inhibition by clonidine. Pain 113: 386-394. (Pubitemid 40127522)
34. Bennett DL (2001) Neurotrophic factors: important regulators of nociceptive function. Neuroscientist 7: 13-17.
35. Zwick M, Davis BM, Woodbury CJ, Burkett JN, Koerber HR, et al. (2002) Glial cell line-derived neurotrophic factor is a survival factor for isolectin B4-positive, but not vanilloid receptor 1-positive, neurons in the mouse. J Neurosci 22: 4057-4065. (Pubitemid 37465714)
36. Gerke MB, Plenderleith MB (2002) Analysis of the distribution of binding sites for the plant lectin Bandeiraea simplicifolia I-isolectin B4 on primary sensory neurones in seven mammalian species. Anat Rec 268: 105-114.
37. Engle MP, Merrill MA, Marquez De Prado B, Hammond DL (2012) Spinal nerve ligation decreases gamma-aminobutyric acidB receptors on specific populations of immunohistochemically identified neurons in L5 dorsal root ganglion of the rat. J Comp Neurol 520: 1663-1677.
38. Ivanusic JJ (2009) Size, neurochemistry, and segmental distribution of sensory neurons innervating the rat tibia. J Comp Neurol 517: 276-283.
39. Niiyama Y, Kawamata T, Yamamoto J, Omote K, Namiki A (2007) Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons. Neuroscience 148: 560-572. (Pubitemid 47362498)
40. Amaya F, Oh-hashi K, Naruse Y, Iijima N, Ueda M, et al. (2003) Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons. Brain Res 963: 190-196. (Pubitemid 36126299)
41. Patapoutian A, Tate S, Woolf CJ (2009) Transient receptor potential channels: targeting pain at the source. Nat Rev Drug Discov 8: 55-68.
42. McCoy ES, Taylor-Blake B, Street SE, Pribisko AL, Zheng J, et al. (2013) Peptidergic CGRPalpha primary sensory neurons encode heat and itch and tonically suppress sensitivity to cold. Neuron 78: 138-151.
43. Schutz B, Mauer D, Salmon AM, Changeux JP, Zimmer A (2004) Analysis of the cellular expression pattern of beta-CGRP in alpha-CGRP-deficient mice. J Comp Neurol 476: 32-43. (Pubitemid 38880231)
44. St Pierre M, Reeh PW, Zimmermann K (2009) Differential effects of TRPV channel block on polymodal activation of rat cutaneous nociceptors in vitro. Exp Brain Res 196: 31-44.
45. Smart D, Jerman JC, Gunthorpe MJ, Brough SJ, Ranson J, et al. (2001) Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology. Eur J Pharmacol 417: 51-58. (Pubitemid 32299868)
46. Mandadi S, Roufogalis BD (2008) ThermoTRP channels in nociceptors: taking a lead from capsaicin receptor TRPV1. Curr Neuropharmacol 6: 21-38. (Pubitemid 351513471)
47. Inoue R, Jian Z, Kawarabayashi Y (2009) Mechanosensitive TRP channels in cardiovascular pathophysiology. Pharmacol Ther 123: 371-385.
48. Shinoda M, Ogino A, Ozaki N, Urano H, Hironaka K, et al. (2008) Involvement of TRPV1 in nociceptive behavior in a rat model of cancer pain. J Pain 9: 687-699.
49. Lambert IH, Pedersen SF, Poulsen KA (2006) Activation of PLA2 isoforms by cell swelling and ischaemia/hypoxia. Acta Physiol (Oxf) 187: 75-85. (Pubitemid 43828765)
50. Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, et al. (2000) Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci U S A 97: 6155-6160. (Pubitemid 30367539)
51. Tang ZY, Shu B, Cui XJ, Zhou CJ, Shi Q, et al. (2009) Changes of cervical dorsal root ganglia induced by compression injury and decompression procedure: a novel rat model of cervical radiculoneuropathy. J Neurotrauma 26: 289-295.
52. Morioka N, Takeda K, Kumagai K, Hanada T, Ikoma K, et al. (2002) Interleukin-1beta-induced substance P release from rat cultured primary afferent neurons driven by two phospholipase A2 enzymes: secretory type IIA and cytosolic type IV. J Neurochem 80: 989-997. (Pubitemid 34809951)